Abstract
Allogeneic bone marrow transplantation (allo-BMT) has been used as a therapeutic procedure for hematologic malignancies and other chemotherapy-unresponsive diseases. Despite the increasing application and expansion of access, allo-BMT is still associated with significant morbidity and mortality. Graft-versus-host disease (GvHD) is the main complication and cause of death after allo-BMT, a…